» Articles » PMID: 33293980

INTERACTS (INTErventional Radiotherapy ACtive Teaching School) Consensus Conference on Sarcoma Interventional Radiotherapy (brachytherapy) Endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology)

Abstract

Purpose: To report the results of INTERACTS (INTErventional Radiotherapy ACtive Teaching School) consensus conference on sarcoma interventional radiotherapy (brachytherapy).

Material And Methods: An international board of multidisciplinary experts was invited to a consensus conference on the state-of-the-art of sarcoma interventional oncology during the 9 Rome INTER-MEETING (INTERventional Radiotherapy Multidisciplinary Meeting), proposing 3 statements for each one speech. At the end of each lecture, the entire group of experts was invited to vote with an electronic device. The preliminary results were presented and discussed at the end of the meeting, during a dedicated session. After the meeting, a survey was distributed within the consensus conference board to share and definitively vote the statements.

Results: All the invited authors of the consensus conference board completed the final survey. All the 38 statements received more than 70% of agreement, 31 statements (82%) obtained an agreement of level higher or equal to 90%, 6 statements (15.8%) received an agreement level between 80% and 90%, and 1 statement (2.6%) had less than 80% of agreement.

Conclusions: The consensus conference demonstrated that interventional radiotherapy must be considered by a multidisciplinary management of patients affected by sarcoma.

Citing Articles

Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: a case report.

Vavassori A, Pennacchioli E, Augugliaro M, Durante S, Dicuonzo S, Orsolini G J Contemp Brachytherapy. 2021; 13(3):338-346.

PMID: 34122575 PMC: 8170520. DOI: 10.5114/jcb.2021.106204.

References
1.
Naghavi A, Fernandez D, Mesko N, Juloori A, Martinez A, Scott J . American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy. 2017; 16(3):466-489. DOI: 10.1016/j.brachy.2017.02.004. View

2.
Livi L, Shah N, Paiar F, Fisher C, Judson I, Moskovic E . Treatment of epithelioid sarcoma at the royal marsden hospital. Sarcoma. 2008; 7(3-4):149-52. PMC: 2395532. DOI: 10.1080/13577140310001644760. View

3.
Greto D, Saieva C, Loi M, Desideri I, Paoli C, Lo Russo M . Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma. Am J Clin Oncol. 2019; 42(10):749-754. DOI: 10.1097/COC.0000000000000594. View

4.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

5.
Baldini E, Cesne A, Trent J . Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue Sarcoma. Am Soc Clin Oncol Educ Book. 2018; 38:910-915. DOI: 10.1200/EDBK_201421. View